LENZ Therapeutics: BML reports 6.7% passive stake

The reported position carries shared voting and disposition authority; sole voting and sole disposition power are each listed as zero.

Available on EDGAR 11/04/2026 - 03:59 PM EST Accepted by SEC EDGAR 11/04/2026 - 03:59 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

LENZ Therapeutics, Inc. is the issuer whose common stock BML Investment Partners, L.P. reported beneficially owning 2,110,727 shares, equal to 6.7% of the class. The report lists shared voting power and shared dispositive power over 2,110,727 shares, with sole voting power and sole dispositive power each listed as 0.

The report was signed by Braden M Leonard, managing member of BML Capital Management, LLC, identified as BML Investment Partners' general partner.

Key Figures

Beneficially owned: 2,110,727 shares Percent of class: 6.7% Shared voting power: 2,110,727 shares +1 more

4 metrics

Beneficially owned 2,110,727 shares LENZ Therapeutics common stock

Percent of class 6.7% BML Investment Partners' reported ownership

Shared voting power 2,110,727 shares LENZ Therapeutics common stock

Shared dispositive power 2,110,727 shares LENZ Therapeutics common stock

Key Terms

beneficially owned, shared voting power, shared dispositive power

3 terms

beneficially owned regulatory

"Amount beneficially owned: 2110727"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power regulatory

"Shared power to vote or to direct the vote: 2110727"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power regulatory

"Shared power to dispose or to direct the disposition of: 2110727"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LENZ shares does BML Investment Partners beneficially own?

BML Investment Partners, L.P. reported beneficial ownership of 2,110,727 LENZ common shares, equal to 6.7% of the class.

What voting power does BML Investment Partners have in LENZ?

The report lists shared voting power over 2,110,727 shares and sole voting power of 0 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

LENZ Therapeutics, Inc.

(Name of Issuer)

Common Stock, $0.00001 par value per share

(Title of Class of Securities)

52635N103

(CUSIP Number)

11/02/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 52635N103

1

Names of Reporting Persons

BML Investment Partners, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,110,727.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,110,727.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,110,727.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.7 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: LENZ Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 201 Lomas Santa Fe Dr., Suite 300 Solana Beach, California 92075
Item 2.
(a)	Name of person filing: BML Investment Partners, L.P.
(b)	Address or principal business office or, if none, residence: 65 E Cedar - Suite 2, Zionsville IN
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock, $0.00001 par value per share
(e)	CUSIP Number(s): 52635N103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2110727
(b)	Percent of class: 6.7 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 2110727
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2110727
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BML Investment Partners, L.P.

Signature:	Braden M Leonard
Name/Title:	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Date:	11/04/2026